Immunotherapy Data is Encouraging in Kidney Cancer – Curetoday.com
|
Immunotherapy Data is Encouraging in Kidney Cancer
Curetoday.com Immunotherapy Data is Encouraging in Kidney Cancer. Elizabeth Plimack, M.D., discusses an update on the CheckMate-025 trial, comparing Opdivo to Afinitor in patients with metastatic renal cell carcinoma. DANIELLE BUCCO. PUBLISHED: JANUARY 25 … |
